|
ZNF737 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.535600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.381200E-01 |
| Normal-vs-Stage2 |
9.677800E-01 |
| Normal-vs-Stage3 |
4.509600E-01 |
| Normal-vs-Stage4 |
9.377900E-02 |
| Stage1-vs-Stage2 |
8.055000E-01 |
| Stage1-vs-Stage3 |
6.588000E-01 |
| Stage1-vs-Stage4 |
3.065200E-01 |
| Stage2-vs-Stage3 |
6.341400E-01 |
| Stage2-vs-Stage4 |
2.939400E-01 |
| Stage3-vs-Stage4 |
4.652200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.850000E-01 |
| Normal-vs-AfricanAmerican |
9.734200E-01 |
| Normal-vs-Asian |
7.543000E-01 |
| Caucasian-vs-AfricanAmerican |
9.314600E-01 |
| Caucasian-vs-Asian |
7.133800E-01 |
| AfricanAmerican-vs-Asian |
6.462800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.868400E-01 |
| Normal-vs-Female |
3.619000E-01 |
| Male-vs-Female |
2.822800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.148000E-01 |
| Normal-vs-Extreme_Weight |
1.014220E-01 |
| Normal-vs-Obese |
5.438000E-01 |
| Normal-vs-Extreme_Obese |
1.757160E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.558380E-01 |
| Normal_Weight-vs-Obese |
8.017600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.498400E-01 |
| Extreme_Weight-vs-Obese |
3.268100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.147000E-01 |
| Obese-vs-Extreme_Obese |
2.141400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.528200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.634200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.924800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.503400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.309580E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.185200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.458000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.635800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.673000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.002800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.352800E-01 |
| Normal-VS-Type2 PRCC |
1.675200E-01 |
| Normal-VS-KIRP CIMP |
4.084000E-03 |
| Normal-VS-Unclassified PRCC |
5.414800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.165500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.649600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.670400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.650400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.391600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.584800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.205800E-01 |
| Normal-vs-N1 |
9.607600E-01 |
| Normal-vs-N2 |
1.536280E-02 |
| N0-vs-N1 |
4.316400E-01 |
| N0-vs-N2 |
1.326180E-01 |
| N1-vs-N2 |
9.616100E-02 |
|
|
